Abbott delivers diagnostic tests that are designed to increase accuracy and drive operational efficiencies. Our expert teams collaborate with laboratories, healthcare professionals and organizations globally. We have an ongoing commitment to providing intuitive, accurate and timely information across the patient journey, as part of our purpose: to help people live better lives.

Diagnoptics is a pioneer in non-invasive diagnostics, offering advanced technology to assess cardiovascular and diabetes risk through rapid measurement of tissue Advanced Glycation Endproducts (AGEs). Recently, a clinical study was initiated in Canada and the U.S. to evaluate the use of the AGE Reader for perioperative risk assessment in same-day surgery patients.

_

Cloud DX is a Canadian digital health leader pioneering virtual care and remote patient monitoring to improve surgical outcomes and support faster recovery. Our Connected Health™ platform, validated in the landmark PVC-RAM trial, brings real-time biometric data, patient engagement tools, and clinician support together to transform perioperative care.

_

Heart and Stroke Foundation/Michael G. DeGroote Endowed Chair of Cardiovascular Nursing, McMaster University

Throughout a 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.